TB CAB 10-Year Anniversary Evaluation Report 2011–2021 and Podcast

This report details an evaluation of the Global Tuberculosis Community Advisory Board after 10 years of functioning, highlighting strengths, identifying challenging, and illuminating the pathway forward. Visit here for the report and accompanying podcast series.

AVAC’s Strategic Plan 2022-2026

AVAC’s strategic framework is grounded in a multi-layered approach that carefully considers all of the components needed to achieve the organization’s vision, capitalize on its key strengths, and ensure that AVAC is poised to make an impact on the issues it cares most about over the next five years, and beyond.

The vision describes the world we are striving for. The mission describes what AVAC does in service to achieving this vision. The strategic pillars outline the objectives and approaches that AVAC will take over the next five years to achieve its mission and vision. The strategic pillars are supported by AVAC’s core values—the principles by which we work—as well as a set of key enablers.

Advocate, Translate, Catalyze: For HIV prevention and health equity

In this document, we look at the actions we are taking and those that as a field we all need to take to transform prevention “options” developed through research into prevention “choices” for people that can save lives and help end epidemics. This work is critical, and it is shared – just as we developed our strategic plan and EDI statement in partnership with so many, so too will we move this work forward, together.

Illustrated Glossary for Long-Acting Technologies

Language is important and how affected communities become familiarized with the technical aspects in emerging fields, such as nanomedicines to treat HIV, hepatitis C virus, TB and malaria, is an essential part of meaningful, equitable engagement in early stage science. The Illustrated Glossary for Long-Acting Technologies compiles frequent terms and concepts used in the research and development of long-acting technologies. The glossary is a non-exhaustive list and the graphics are artistic renderings meant to spur discussion and assist with community treatment literacy.

2021 Pipeline Report

The Treatment Action Group Pipeline Report provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV) and tuberculosis (TB).

Read the report on the Treatment Action Group website.

How Can We End the Tuberculosis Epidemic? Lessons from Around the World

Anyone can get TB. In 2019, an estimated 10 million people contracted TB and more than 1.4 million died. Despite the numbers, we know we can end the TB epidemic. It is a matter of scaling up effective programs, dedicating sufficient resources and mobilizing the political will. This report highlights six locations where communities made impressive progress to significantly reduce TB cases and deaths – from California in the United States to Tomsk, Russia and Karachi, Pakistan.

Antiretroviral Treatment for Prevention of HIV and Tuberculosis

Despite considerable evidence supporting the use of antiretroviral therapy (ART) for prevention of HIV and TB illness, death and transmission, only 37 percent of the 35 million people living with HIV were receiving it in 2013. This paper examines ongoing and planned global treatment as prevention studies and addresses research questions related to access and implementation.

Good Participatory Practice: Guidelines for TB Drug Trials

The Good Participatory Practice (GPP) guidelines for TB Drug Trials is the product of a collaboration between AVAC and the Stakeholder and Community Engagement Workgroup of the Critical Path to TB Drug Regimens. The guidelines offer trial funders, sponsors, and implementers systematic guidance on how to engage stakeholders throughout the research lifecycle. This first edition, published in 2012, contains five sections that provide context, foundational principles, and key practices for conducting TB drug trials.  

GPP Overview PowerPoint

The GPP Overview PowerPoint contains 35 slides that users can draw from when introducing the Good Participatory Practice guidelines.  The PowerPoint contains slides on the history and content of the guidelines, who the intended user is,  the role and importance of GPP in the field and strategies for effective use. The slide deck is broken into sections allowing slides can be rearranged or deleted to make a complete presentation.